Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967343 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 1 Receptor, Type I (IL1R1) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Purified from tissue culture supernatant or ascites by affinity chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- hIL1R-M1
- Vial size
- 0.5 mg
- Concentration
- 0.5 mg/ml
- Storage
- 4°C
Submitted references Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.
CD121a.
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.
Genomic organization of the type I and type II IL-1 receptors.
The two interleukin-1 receptors play different roles in IL-1 actions.
Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE
The Journal of biological chemistry 2000 Sep 29;275(39):29946-54
The Journal of biological chemistry 2000 Sep 29;275(39):29946-54
CD121a.
Sims JE
Journal of biological regulators and homeostatic agents 2000 Apr-Jun;14(2):133-5
Journal of biological regulators and homeostatic agents 2000 Apr-Jun;14(2):133-5
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.
Bernstein SH, Fay J, Frankel S, Christiansen N, Baer MR, Jacobs C, Blosch C, Hanna R, Herzig G
Cancer chemotherapy and pharmacology 1999;43(2):141-4
Cancer chemotherapy and pharmacology 1999;43(2):141-4
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.
Bernstein SH, Fay J, Frankel S, Christiansen N, Baer MR, Jacobs C, Blosch C, Hanna R, Herzig G
Cancer chemotherapy and pharmacology 1999;43(2):141-4
Cancer chemotherapy and pharmacology 1999;43(2):141-4
Genomic organization of the type I and type II IL-1 receptors.
Sims JE, Painter SL, Gow IR
Cytokine 1995 Aug;7(6):483-90
Cytokine 1995 Aug;7(6):483-90
The two interleukin-1 receptors play different roles in IL-1 actions.
Sims JE, Giri JG, Dower SK
Clinical immunology and immunopathology 1994 Jul;72(1):9-14
Clinical immunology and immunopathology 1994 Jul;72(1):9-14
No comments: Submit comment
No validations: Submit validation data